{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:22:06Z","timestamp":1794007326807,"version":"4.8.0"},"reference-count":173,"publisher":"Hindawi Limited","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1814,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1111\/j.1365-2710.2009.01107.x","type":"journal-article","created":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T23:35:24Z","timestamp":1284507324000},"page":"497-519","source":"Crossref","is-referenced-by-count":278,"title":["REVIEW ARTICLE: Toenail onychomycosis: an important global disease burden"],"prefix":"10.1155","volume":"35","author":[{"given":"J.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. K.","family":"Narkowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. M.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Burnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2010,9,13]]},"reference":[{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00128071-200001010-00002","article-title":"Onychomycosis: treatment, quality of life, and economic issues","volume":"1","author":"Elewski","year":"2000","journal-title":"American Journal of Clinical Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1468-3083.2004.00988.x","article-title":"Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy","volume":"19","author":"Baran","year":"2005","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0733-8635(02)00086-4","article-title":"Non-dermatophyte onychomycosis","volume":"21","author":"Gupta","year":"2003","journal-title":"Dermatologic Clinics"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1439-0507.2006.01351.x","article-title":"Onychomycosis","volume":"50","author":"Seebacher","year":"2007","journal-title":"Mycoses"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/00002512-200724040-00003","article-title":"Onychomycosis in the elderly: drug treatment options","volume":"24","author":"Loo","year":"2007","journal-title":"Drugs and Aging"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0190-9622(03)02117-0","article-title":"Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002","volume":"50","author":"Foster","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00003495-199958020-00005","article-title":"Management of onychomycoses","volume":"58","author":"Niewerth","year":"1999","journal-title":"Drugs"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.det.2006.03.008","article-title":"Diagnosing onychomycosis","volume":"24","author":"Gupta","year":"2006","journal-title":"Dermatologic Clinics"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1529-8019.2007.00109.x","article-title":"Toenail onychomycosis: current and future treatment options","volume":"20","author":"Finch","year":"2007","journal-title":"Dermatologic Therapy"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB10|cit10","first-page":"87","article-title":"Cutaneous infections dermatophytosis, onychomycosis, and tinea versicolor","volume":"17","author":"Vander","year":"2003","journal-title":"Infectious Disease Clinics of North America"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-3083.2005.01281.x","article-title":"Epidemiology and clinical classification of onychomycosis","volume":"19","author":"Effendy","year":"2005","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1346-8138.2007.00310.x","article-title":"Effects of foot care intervention including nail drilling combined with topical antifungal application in diabetic patients with onychomycosis","volume":"34","author":"Sumikawa","year":"2007","journal-title":"The Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1439-0507.2003.00855.x","article-title":"Clinical and mycological study of occult tinea pedis and tinea unguium in dermatological patients from Tokyo","volume":"46","author":"Ogasawara","year":"2003","journal-title":"Mycoses"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1439-0507.2006.01230.x","article-title":"Epidemiological and aetiological study on tinea pedis and onychomycosis in Algeria","volume":"49","author":"Djeridane","year":"2006","journal-title":"Mycoses"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00002512-200421020-00003","article-title":"Common fungal infections of the feet in patients with diabetes mellitus","volume":"21","author":"Tan","year":"2004","journal-title":"Drugs and Aging"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s001050051265","article-title":"A medical student discovers onychomycosis","volume":"52","author":"Haas","year":"2001","journal-title":"Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und Verwandte Gebiete"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB17|cit17","first-page":"43","article-title":"A historical perspective on onychomycosis","volume":"3","author":"Charif","year":"1997","journal-title":"Dermatologic Therapy"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB18|cit18","first-page":"169","volume-title":"Medical mycology: the pathogenic fungi and the pathogenic actinomycetes","author":"Rippon","year":"1988"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/archderm.1927.02370280031002","article-title":"The laboratory aspects of dermatophytosis","volume":"15","author":"Weidman","year":"1927","journal-title":"Archives of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB20|cit20","first-page":"1","article-title":"Onychomycosis disease management","volume":"4","author":"Salgo","year":"2003","journal-title":"Medical Crossfire: debates, peer exchange and insights in medicine"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB21|cit21","first-page":"1","volume-title":"Clinical dermatology","author":"Elewski","year":"1993"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000254927","article-title":"Tinea pedis in schoolchildren (an epidemiological study)","volume":"126","author":"Ganor","year":"1963","journal-title":"Dermatologica"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1067\/S0190-9622(03)01480-4","article-title":"Comparison of diagnostic methods in the evaluation of onychomycosis","volume":"49","author":"Weinberg","year":"2003","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1046\/j.1365-4362.1997.00349.x","article-title":"Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists\u2019 offices in Ontario, Canada - a multicenter survey of 2001 patients","volume":"36","author":"Gupta","year":"1997","journal-title":"International Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2133.1995.tb02741.x","article-title":"The prevalence of onychomycosis in Finland","volume":"133","author":"Heikkila","year":"1995","journal-title":"British Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1067\/mjd.2000.104794","article-title":"Prevalence and epidemiology of onychomycosis in patients visiting physicians\u2019 offices: a multicenter Canadian survey of 15,000 patients","volume":"43","author":"Gupta","year":"2000","journal-title":"Journal of American Academy of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0733-8635(18)30884-2","article-title":"Onychomycosis","volume":"3","author":"Zaias","year":"1985","journal-title":"Dermatology Clinics"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB28|cit28","first-page":"106","volume-title":"Cutaneous fungal infections","author":"Cohen","year":"1992"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/1523-1747.ep12541101","article-title":"Prevalence, morbidity, and cost of dermatological diseases","volume":"73","author":"Editorial","year":"1979","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/archderm.1997.03890450124022","article-title":"Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions","volume":"33","author":"Elewski","year":"1997","journal-title":"Archives of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1067\/mjd.2000.107754","article-title":"A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns","volume":"43","author":"Ghannoum","year":"2000","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3314\/jjmm.46.171","article-title":"Epidemiology of onychomycosis in Indonesia: data obtained from three individual studies","volume":"46","author":"Bramono","year":"2005","journal-title":"Japanese Journal of Medical Mycology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1365-4362.1999.00015.x","article-title":"The scope of onychomycosis: epidemiology and clinical features","volume":"38","author":"Haneke","year":"1999","journal-title":"International Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1468-3083.2005.01282.x","article-title":"Patients at risk of onychomycosis-risk factor identification and active prevention","volume":"19","author":"Tosti","year":"2005","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB35|cit35","first-page":"151","article-title":"Frequency of onychomycoses caused by yeasts in Maringa, Parana, Brazil","volume":"82","author":"Eliane Alves","year":"2007","journal-title":"Anais Brasileiros de Dermatologia"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1128\/JCM.26.10.2110-2115.1988","article-title":"Dermatophyte-hormone relationships: characterization of progesterone-binding specificity and growth inhibition in the genera Trichophyton and Microsporum","volume":"26","author":"Clemons","year":"1988","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1590\/S0365-05962003000300006","article-title":"Occurrence of onychomycosis among patients attended in dermatology offices in the city of Rio de Janeiro, Brazil","volume":"78","author":"Ara\u00fajo","year":"2003","journal-title":"Anais Brasileiros de Dermatologia"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.0736-8046.2004.21117.x","article-title":"Onychomycosis in children: a brief overview with treatment strategies","volume":"21","author":"Gupta","year":"2004","journal-title":"Paediatric Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0190-9622(97)80215-0","article-title":"Onychomycosis in children: prevalence and treatment strategies","volume":"36","author":"Gupta","year":"1997","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB40|cit40","first-page":"15","article-title":"A role of the genetic factors in the onychomycosis development. Allele frequency distribution of polymorphic genes","volume":"6","author":"Spitsyn","year":"2007","journal-title":"Meditsinskaya Genetika"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0190-9622(96)80142-3","article-title":"Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum","volume":"34","author":"Zaias","year":"1996","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1468-3083.2005.01283.x","article-title":"Genetic predisposition: understanding underlying mechanisms of onychomycosis","volume":"19","author":"Faergemann","year":"2005","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2133.149.s65.4.x","article-title":"Epidemiology, clinical presentation and diagnosis of onychomycosis","volume":"149","author":"Faergemann","year":"2003","journal-title":"British Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jaad.2004.11.055","article-title":"An update on disorders of the nails","volume":"52","author":"Nandedkar-Thomas","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/0019-5154.31923","article-title":"A five-year survey of onychomycosis in New Delhi, India: Epidemiological and laboratory aspects","volume":"52","author":"Kaur","year":"2007","journal-title":"Indian Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/CMR.11.3.415","article-title":"Onychomycosis: pathogenesis, diagnosis and management","volume":"11","author":"Elewski","year":"1998","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB47|cit47","first-page":"633","article-title":"Onychomycosis: predisposed populations and some predictors of suboptimal response to oral antifungal agents","volume":"9","author":"Gupta","year":"1999","journal-title":"European Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11046-004-5493-2","article-title":"A prospective epidemiologic survey on the prevalence of onychomycosis and dermatophytosis in male boarding school residents","volume":"159","author":"Erbagci","year":"2005","journal-title":"Mycopathologia"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11046-007-9024-9","article-title":"Onychomycosis by Scytalidium dimidiatum in green tea leaf pluckers: report of two cases","volume":"164","author":"Barua","year":"2007","journal-title":"Mycopathologia"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4103\/0378-6323.37055","article-title":"Onychomycosis: clinico-mycologic study of 130 patients from Himachal Pradesh, India","volume":"73","author":"Gupta","year":"2007","journal-title":"Indian Journal of Dermatology, Venereology and Leprology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1365-2133.2003.05242.x","article-title":"Guidelines for treatment of onychomycosis","volume":"148","author":"Roberts","year":"2003","journal-title":"British Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1439-0507.1995.tb00029.x","article-title":"Fungal contamination of the floors of swimming pools, particularly subtropical swimming paradises","volume":"38","author":"Detandt","year":"1995","journal-title":"Mycoses"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/09603120701254862","article-title":"Swimming pools and fungi: an environmental epidemiology survey in Italian indoor swimming facilities","volume":"17","author":"Brandi","year":"2007","journal-title":"International Journal of Environmental Health Research"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/000155599750010319","article-title":"Onychomycosis in Icelandic swimmers","volume":"79","author":"Gudnad\u00f3ttir","year":"1999","journal-title":"Acta Dermato-Venereologica"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S1130-1406(05)70004-8","article-title":"Fungal infection of the feet in soccer players and non-athlete individuals","volume":"22","author":"Purim","year":"2005","journal-title":"Revista Iberoamericana de Micologia: Organo de la Asociacion Espanola de Especialistas en Micologia"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0030-5898(20)31877-0","article-title":"Conditions of the toenails","volume":"25","author":"Eisele","year":"1994","journal-title":"The Orthopaedic Clinics of North America"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB57|cit57","first-page":"312","article-title":"Prevalence of superficial fungal infections among sports-active individuals: results from the Achilles survey, a review of the literature","volume":"15","author":"Caputo","year":"2001","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/09546630701657187","article-title":"Review of antifungal therapy, part II: treatment rationale, including specific patient populations","volume":"19","author":"Baran","year":"2008","journal-title":"Journal of Dermatological Treatment"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1067\/S0190-9622(03)00861-2","article-title":"Superficial fungal infections in 102 renal transplant recipients: a case-control study","volume":"49","author":"Gulec","year":"2003","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0733-8635(03)00026-3","article-title":"How to improve cure rates for the management of onychomycosis","volume":"21","author":"Gupta","year":"2003","journal-title":"Dermatologic Clinics"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1365-2133.1998.02464.x","article-title":"Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey","volume":"139","author":"Gupta","year":"1998","journal-title":"British Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9610(03)00299-X","article-title":"Protocol for treatment of diabetic foot ulcers","volume":"187","author":"Brem","year":"2004","journal-title":"The American Journal of Surgery"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1365-4362.2002.01528.x","article-title":"Epidemiology of onychomycosis in patients with diabetes mellitus in India","volume":"41","author":"Dogra","year":"2002","journal-title":"International Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2337\/diaclin.24.4.160","article-title":"Treatment of onychomycosis in diabetic patients","volume":"24","author":"Winston","year":"2006","journal-title":"Clinical Diabetes"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1046\/j.1468-3083.2000.00124.x","article-title":"The epidemiology of onychomycosis: possible role of smoking and peripheral arterial disease","volume":"14","author":"Gupta","year":"2000","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB66|cit66","first-page":"363","article-title":"Structural characteristics and permeability properties of the human nail: a review","volume":"50","author":"Gupchup","year":"1999","journal-title":"Journal of Cosmetic Science"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0733-8635(03)00035-4","article-title":"The diagnosis of onychomycosis","volume":"21","author":"Mahoney","year":"2003","journal-title":"Dermatologic Clinics"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1211\/0022357991772448","article-title":"Drug permeation through the three layers of the human nail plate","volume":"51","author":"Kobayashi","year":"1999","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaad.2003.07.011","article-title":"Modulation of linear nail growth to treat diseases of the nail","volume":"50","author":"Geyer","year":"2004","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/09546639709160278","article-title":"Comparative multicentre double-blind study of terbinafine (250\u2003mg per day) vs. griseofulvin (1\u2003g per day) in the treatment of dermatophyte onychomycosis","volume":"8","author":"Baran","year":"1997","journal-title":"Journal of Dermatological Treatment"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB71|cit71","first-page":"180","article-title":"A dermatologic diary: portrait of a practice","volume":"49","author":"Shelley","year":"1992","journal-title":"Cutis"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB72|cit72","first-page":"48","article-title":"Brittle nails: pathogenesis and treatment","volume":"2","author":"Uyttendaele","year":"2003","journal-title":"Journal of Drugs in Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2230.1994.tb02693.x","article-title":"Acquired nail beading in patients receiving itraconazole - an indicator of faster nail growth? A study using optical profilometry","volume":"19","author":"Doncker","year":"1994","journal-title":"Clinical and Experimental Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2005.01288.x","article-title":"Literature review: onychomycosis","volume":"19","author":"Hay","year":"2005","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1046\/j.1365-2133.1998.02449.x","article-title":"A new classification of onychomycosis","volume":"139","author":"Baran","year":"1998","journal-title":"British Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB76|cit76","first-page":"663","article-title":"Treating onychomycosis","volume":"63","author":"Rodgers","year":"2001","journal-title":"American Family Physician"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1440-0960.2002.t01-1-00570.x","article-title":"Onychomycosis of toenails: orthopaedic and podiatric considerations","volume":"43","author":"Murray","year":"2002","journal-title":"Australasian Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jaad.2007.05.026","article-title":"Superficial white onychomycosis: a syndrome with different fungal causes and paths of infection","volume":"57","author":"Baran","year":"2007","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0733-8635(03)00036-6","article-title":"Treatment of nondermatophyte mold and Candida onychomycosis","volume":"21","author":"Tosti","year":"2003","journal-title":"Dermatologic Clinics"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0733-8635(02)00086-4","article-title":"Non-dermatophyte onychomycosis","volume":"21","author":"Gupta","year":"2003","journal-title":"Dermatologic Clinics"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.idc.2007.07.006","article-title":"Infection in the elderly","volume":"21","author":"Htwe","year":"2007","journal-title":"Infectious Disease Clinics of North America"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1529-8019.2002.01524.x","article-title":"Onychomycosis: diagnosis and topical therapy","volume":"15","author":"Fleckman","year":"2002","journal-title":"Dermatologic Therapy"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jaad.2006.01.016","article-title":"Dermatophytes: diagnosis and treatment","volume":"54","author":"Gupta","year":"2006","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jaad.2006.12.019","article-title":"Onychomycosis: diagnosis and definition of cure","volume":"56","author":"Scher","year":"2007","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000073086","article-title":"Treatment failures and relapses in onychomycosis: a stubborn clinical problem","volume":"207","author":"Arrese","year":"2003","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1001\/archderm.136.9.1112","article-title":"Methods for diagnosing onychomycosis: a comparative study and review of the literature","volume":"136","author":"Lawry","year":"2000","journal-title":"Archives of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.det.2006.03.001","article-title":"Common nail disorders","volume":"24","author":"Holzberg","year":"2006","journal-title":"Dermatologic Clinics"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.det.2006.03.009","article-title":"Onychomycosis therapies: strategies to improve efficacy","volume":"24","author":"Gupta","year":"2006","journal-title":"Dermatologic Clinics"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1365-2133.1997.tb03673.x","article-title":"A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics: a multicentre study","volume":"136","author":"Gupta","year":"1997","journal-title":"British Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB90|cit90","first-page":"8","article-title":"Nail disorders that mimic onychomycosis: what to consider","volume":"68","author":"Lynde","year":"2001","journal-title":"Cutis"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1365-2133.2005.06862.x","article-title":"Diagnosis of nail psoriasis: importance of biopsy and histopathology","volume":"153","author":"Grover","year":"2005","journal-title":"British Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-200022010-00004","article-title":"A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis","volume":"22","author":"Gupta","year":"2000","journal-title":"Drug Safety"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"546","DOI":"10.7547\/87507315-87-12-546","article-title":"Epidemiology of onychomycosis in special-risk populations","volume":"87","author":"Levy","year":"1997","journal-title":"Journal of the American Podiatric Medical Association"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB94|cit94","volume-title":"Diabetes Atlas","author":"International Diabetes Federation","year":"2003"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0190-9622(99)70047-2","article-title":"The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life","volume":"1","author":"Drake","year":"1999","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1046\/j.1365-4362.1997.00163.x","article-title":"The effect of toenail onychomycosis on patient quality of life","volume":"36","author":"Elewski","year":"1997","journal-title":"International Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2133.2001.145s60003.x","article-title":"The future of onychomycosis therapy may involve a combination of approaches","volume":"145","author":"Hay","year":"2001","journal-title":"British Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2230.1997.tb02626.x","article-title":"The impact of onychomycosis on quality of life","volume":"22","author":"Whittam","year":"1997","journal-title":"Clinical and Experimental Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.det.2006.03.010","article-title":"Therapies for onychomycosis: a review","volume":"24","author":"Gupta","year":"2006","journal-title":"Dermatologic Clinics"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/120347540400800107","article-title":"Treatment of onychomycosis: pros and cons of antifungal agents","volume":"8","author":"Gupta","year":"2004","journal-title":"Journal of Cutaneous Medicine and Surgery"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-2230.2003.01308.x","article-title":"Prediction of outcome in the treatment of onychomycosis","volume":"28","author":"Sommer","year":"2003","journal-title":"Clinical and Experimental Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2133.1998.02050.x","article-title":"Subungual dermatophytoma complicating dermatophyte onychomycosis","volume":"138","author":"Roberts","year":"1998","journal-title":"British Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/09546630701243418","article-title":"Review of antifungal therapy and the severity index for assessing onychomycosis: Part I","volume":"19","author":"Baran","year":"2008","journal-title":"Journal of Dermatological Treatment"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB104|cit104","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/0378-6323.37052","article-title":"Current treatment of onychomycosis","volume":"73","author":"Thappa","year":"2007","journal-title":"Indian Journal of Dermatology, Venereology and Leprology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1517\/17425247.2.3.435","article-title":"Treatment of onychomycosis with oral antifungal agents","volume":"2","author":"Iorrizo","year":"2005","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB106|cit106","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0733-8635(03)00027-5","article-title":"The use of oral antifungal agents to treat onychomycosis","volume":"21","author":"Gupta","year":"2003","journal-title":"Dermatologic Clinics"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB107|cit107","first-page":"199","volume-title":"Therapeutic guidelines","year":"2008"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB108|cit108","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1365-2133.2003.05728.x","article-title":"Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis","volume":"150","author":"Gupta","year":"2004","journal-title":"British Journal Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB109|cit109","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.det.2007.01.002","article-title":"Advances in topical and systemic antifungals","volume":"25","author":"Zhang","year":"2007","journal-title":"Dermatologic Clinics"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB110|cit110","volume-title":"Nail Infections","author":"Australian Medicines Handbook","year":"2007"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB111|cit111","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/CMR.1.2.187","article-title":"Overview of medically important antifungal azole derivatives","volume":"1","author":"Fromtling","year":"1988","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB112|cit112","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0733-8635(03)00024-X","article-title":"New antifungal agents","volume":"21","author":"Gupta","year":"2003","journal-title":"Dermatologic Clinics"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB113|cit113","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hep.510250119","article-title":"Hepatic injury during ketoconazole therapy in patients with onychomycosis: a controlled cohort study","volume":"25","author":"Chien","year":"1997","journal-title":"Hepatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB114|cit114","volume-title":"Fluconazole","author":"Drug Evaluation Monograph","year":"2004"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2165\/00003495-198937030-00003","article-title":"Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses","volume":"37","author":"Grant","year":"1989","journal-title":"Drugs"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB116|cit116","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0190-9622(92)70102-L","article-title":"Post treatment itraconazole levels in the nail. New implications for treatment in onychomycosis","volume":"26","author":"Willemsen","year":"1992","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB117|cit117","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.amjmed.2007.03.021","article-title":"The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis","volume":"120","author":"Chang","year":"2007","journal-title":"The American Journal of Medicine"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB118|cit118","volume-title":"Lamisil (Terbinafine Hydrochloride Tablets)","author":"Prescribing Information","year":"2001"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB119|cit119","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/bmj.318.7190.1031","article-title":"Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group","volume":"318","author":"Evans","year":"1999","journal-title":"British Medical Journal"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB120|cit120","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1046\/j.1365-2133.2002.04639.x","article-title":"Long-term results in patients with onychomycosis treated with terbinafine or itraconazole","volume":"146","author":"Heikkila","year":"2002","journal-title":"British Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB121|cit121","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2165\/00003495-199855050-00004","article-title":"An overview of topical antifungal therapy in dermatomycoses: a North American perspective","volume":"55","author":"Gupta","year":"1998","journal-title":"Drugs"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB122|cit122","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0733-8635(03)00025-1","article-title":"The use of topical therapies to treat onychomycosis","volume":"21","author":"Gupta","year":"2003","journal-title":"Dermatologic Clinics"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB123|cit123","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0926-9959(94)00075-B","article-title":"Amorolfine nail lacquer: a novel formulation","volume":"5","author":"Marty","year":"1995","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB124|cit124","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2230.1992.tb00277.x","article-title":"Comparative efficacy and safety of amorolfine nail lacquer 2% vs. 5% once weekly","volume":"17","author":"Lauharanta","year":"1992","journal-title":"Clinical and Experimental Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB125|cit125","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/00015550152384425","article-title":"Recurrence of fungal nail disease and the dissociation of relapse from re-infection","volume":"81","author":"Shuster","year":"2001","journal-title":"Acta Dermato-Venereologica"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB126|cit126","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2230.1992.tb00270.x","article-title":"Preclinical data and mode of action of amorolfine","volume":"17","author":"Polak","year":"1992","journal-title":"Clinical and Experimental Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB127|cit127","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2230.1992.tb00278.x","article-title":"Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly","volume":"17","author":"Reinel","year":"1992","journal-title":"Clinical and Experimental Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB128|cit128","volume-title":"Penlac Nail Lacquer (Ciclopirox) Topical Solution","author":"Product Monograph","year":"2000"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB129|cit129","doi-asserted-by":"crossref","first-page":"491","DOI":"10.7547\/87507315-90-10-491","article-title":"The dermatopharmacologic profile of ciclopirox 8% nail lacquer","volume":"10","author":"Bohn","year":"2000","journal-title":"Journal of the American Podiatric Medical Association"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB130|cit130","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7547\/87507315-90-10-495","article-title":"Ciclopirox 8% nail lacquer in the treatment of onychomycosis of the toenails in the United States","volume":"90","author":"Gupta","year":"2000","journal-title":"Journal of the American Podiatric Medical Association"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB131|cit131","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1067\/mjd.2000.109071","article-title":"Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis","volume":"43","author":"Gupta","year":"2000","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB132|cit132","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2133.149.s65.2.x","article-title":"Combination therapy for onychomycosis","volume":"149","author":"Olafsson","year":"2003","journal-title":"British Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB133|cit133","first-page":"481","article-title":"Ciclopirox topical solution, 8% combined with oral terbinafine to treat onychomycosis: a randomized, evaluator-blinded study","volume":"4","author":"Gupta","year":"2005","journal-title":"Journal of Drugs in Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB134|cit134","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1046\/j.1365-2133.2000.03545.x","article-title":"A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region","volume":"142","author":"Baran","year":"2000","journal-title":"British Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB135|cit135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2133.2001.145s60021.x","article-title":"Amorolfine and itraconazole combination for severe toenail onychomycosis: results of an open randomized trial in Spain","volume":"145","author":"Lecha","year":"2001","journal-title":"British Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB136|cit136","first-page":"5","article-title":"Management of onychomycosis: examining the role of monotherapy and dual, triple, or quadruple therapies","volume":"74","author":"Gupta","year":"2004","journal-title":"Cutis"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB137|cit137","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/09546630500420183","article-title":"Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis","volume":"16","author":"Avner","year":"2005","journal-title":"Journal of Dermatological Treatment"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB138|cit138","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4103\/0378-6323.37056","article-title":"An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis","volume":"73","author":"Jaiswal","year":"2007","journal-title":"Indian Journal of Dermatology, Venereology and Leprology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB139|cit139","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/09546630410025988","article-title":"Testing of antifungal combinations against yeasts and dermatophytes","volume":"15","author":"Harman","year":"2004","journal-title":"The Journal of Dermatological Treatment"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB140|cit140","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00128071-200102050-00002","article-title":"A plea to bridge the gap between antifungals and the management of onychomycosis","volume":"2","author":"Arrese","year":"2001","journal-title":"American Journal of Clinical Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB141|cit141","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/mmy.38.5.391.392","article-title":"The boosted antifungal topical treatment (BATT) for onychomycosis","volume":"38","author":"Pierard","year":"2000","journal-title":"Medical Mycology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB142|cit142","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000018363","article-title":"The boosted oral antifungal treatment for onychomycosis beyond the regular itraconazole pulse dosing regimen","volume":"200","author":"Pierard","year":"2000","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB143|cit143","article-title":"Toenail fungus: drill to kill. Delivering antifungal medicine through holes in the infected nail may make it more effective","volume":"32","author":"Anonymous","year":"2007","journal-title":"Harvard health letter from Harvard Medical School"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB144|cit144","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1440-0960.1998.tb01477.x","article-title":"Factors that may affect the response of onychomycosis to oral antifungal therapy","volume":"39","author":"Gupta","year":"1998","journal-title":"The Australasian Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB145|cit145","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-4362.1998.00357.x","article-title":"Oral treatment schedules for onychomycosis: a study of patient preference","volume":"37","author":"Nolting","year":"1998","journal-title":"International Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB146|cit146","first-page":"988","article-title":"Study on the compliance and safety of the oral antifungal agents for the treatment of onychomycosis","volume":"26","author":"Hu","year":"2005","journal-title":"Zhonghua Liuxingbingxue Zazhi"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB147|cit147","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-4362.1999.00012.x","article-title":"Pharmacoeconomic analysis of the new oral antifungal agents used to treat toenail onychomycosis in the USA","volume":"38","author":"Gupta","year":"1999","journal-title":"International Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB148|cit148","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/09546630500375965","article-title":"Treatment costs of three nail lacquers used in onychomycosis","volume":"16","author":"Marty","year":"2005","journal-title":"The Journal of Dermatological Treatment"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB149|cit149","first-page":"379","article-title":"The prevalence and management of onychomycosis in diabetic patients","volume":"10","author":"Gupta","year":"2000","journal-title":"European Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB150|cit150","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00007611-199906000-00008","article-title":"Diabetes-related lower-extremity amputations disproportionately affect Blacks and Mexican Americans","volume":"92","author":"Lavery","year":"1999","journal-title":"Southern Medical Journal"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB151|cit151","volume-title":"Foot health week 2004, diabetes? Check your feet","author":"Australasian Podiatry Council","year":"2004"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB152|cit152","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1007\/s00125-006-0431-0","article-title":"Predictors, consequences and costs of diabetes-related lower extremity amputation complicating type 2 diabetes: the Fremantle Diabetes Study","volume":"49","author":"Davis","year":"2006","journal-title":"Diabetologia"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB153|cit153","unstructured":"Hayutin AM 2007 How population aging differs~across countries: a briefing on global demographics. Stanford Centre on longevity http:\/\/longevity.stanford.edu\/files\/BriefingGlobalDemographics_0.pdf"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB154|cit154","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/ajd.1998.39.2.131","article-title":"What is the cost of onychomycosis?","volume":"39","author":"Sinclair","year":"1998","journal-title":"The Australasian Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB155|cit155","first-page":"10","article-title":"Onychomycosis: review of recurrence rates, poor prognostic factors, and strategies to prevent disease recurrence","volume":"74","author":"Gupta","year":"2004","journal-title":"Cutis"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB156|cit156","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1099\/jmm.0.46474-0","article-title":"Arthroconidia production in Trichophyton rubrum and a new ex vivo model of onychomycosis","volume":"55","author":"Yazdanparast","year":"2006","journal-title":"Journal of Medical Microbiology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB157|cit157","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000093862","article-title":"Spores, sporodochia and fomites in onychomycosis","volume":"2","author":"Pierard","year":"2006","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB158|cit158","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1128\/AAC.37.10.2064","article-title":"Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole","volume":"37","author":"Korting","year":"1993","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB159|cit159","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/0190-9622(95)91454-4","article-title":"Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis","volume":"32","author":"Faergemann","year":"1995","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB160|cit160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2133.1992.tb00013.x","article-title":"Special features of the clinical use of oral terbinafine in the treatment of fungal diseases","volume":"126","author":"Villars","year":"1992","journal-title":"British Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB161|cit161","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-4362.1996.tb03645.x","article-title":"Onychomycosis treated with a short course of oral terbinafine","volume":"35","author":"Galimberti","year":"1996","journal-title":"International Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB162|cit162","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0190-9622(97)70111-7","article-title":"Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial","volume":"37","author":"Drake","year":"1997","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB163|cit163","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/bmj.304.6835.1151","article-title":"Short-term treatment of dermatophyte onychomycosis with terbinafine","volume":"304","author":"Goodfield","year":"1992","journal-title":"British Medical Journal"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB164|cit164","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/09546630500504713","article-title":"Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison","volume":"17","author":"Sigurgeirsson","year":"2006","journal-title":"Journal of Dermatological Treatment"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB165|cit165","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2133.1996.tb15653.x","article-title":"A 12-week treatment for dermatophyte toe onychomycosis: terbinafine 250\u2003mg\/day vs. itraconazole 200\u2003mg\/day - a double-blind comparative trial","volume":"134","author":"De Backer","year":"1996","journal-title":"British Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB166|cit166","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/09546639909056039","article-title":"Open randomized comparison of different itraconazole regimens for the treatment of onychomycosis","volume":"10","author":"Shemer","year":"1999","journal-title":"Journal of Dermatological Treatment"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB167|cit167","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archderm.138.3.353","article-title":"Long-term effectiveness of treatment with terbinafine vs. itraconazole in onychomycosis: a 5-year blinded prospective follow-up study","volume":"138","author":"Sigurgeirsson","year":"2002","journal-title":"Archives of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB168|cit168","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2133.1999.00009.x","article-title":"Long-term outcomes in the treatment of toenail onychomycosis","volume":"141","author":"De Cuyper","year":"1999","journal-title":"British Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB169|cit169","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2133.2000.03247.x","article-title":"A double-blind, randomized study to compare the efficacy and safety of terbinafine (Lamisil) with fluconazole (Diflucan) in the treatment of onychomycosis","volume":"142","author":"Havu","year":"2000","journal-title":"British Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB170|cit170","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0190-9622(98)70492-X","article-title":"Once-weekly fluconazole (450\u2003mg) for 4, 6, or 9\u2003months of treatment for distal subungual onychomycosis of the toenail","volume":"38","author":"Ling","year":"1998","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB171|cit171","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/archderm.138.6.811","article-title":"Oral treatments for toenail onychomycosis: a systematic review","volume":"138","author":"Crawford","year":"2002","journal-title":"Archives of Dermatology"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB172|cit172","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00019053-199813020-00007","article-title":"Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis","volume":"13","author":"Gupta","year":"1998","journal-title":"PharmacoEconomics"},{"key":"10.1111\/j.1365-2710.2009.01107.x-BIB173|cit173","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.csm.2005.03.008","article-title":"Training room management of medical conditions: sports dermatology","volume":"24","author":"Cordoro","year":"2005","journal-title":"Clinics in Sports Medicine"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2710.2009.01107.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2710.2009.01107.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:03:25Z","timestamp":1671818605000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2710.2009.01107.x"}},"subtitle":["Toenail onychomycosis: an important global disease burden"],"short-title":[],"issued":{"date-parts":[[2010,9,13]]},"references-count":173,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2710.2009.01107.x","relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9,13]]}}}